National Medal of Technology and Innovation Nomination Evaluation Committee Meeting, 68167 [2011-28500]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 213 / Thursday, November 3, 2011 / Notices
owner Scripps Research Institute, timely
filed an application under 35 U.S.C.
156(d)(5) for an additional interim
extension of the term of U.S. Patent No.
5,407,914. The patent claims the human
drug product, SURFAXIN®
(lucinactant), and a method of using
SURFAXIN® (lucinactant). The
application indicates that a New Drug
Application, NDA No. 21–746, for the
human drug product SURFAXIN®
(lucinactant) has been filed, and is
currently undergoing regulatory review
before the Food and Drug
Administration for permission to market
or use the product commercially.
Review of the application indicates
that, except for permission to market or
use the product commercially, the
subject patent would be eligible for an
extension of the patent term under 35
U.S.C. 156, and that the patent should
be extended for an additional one year
as required by 35 U.S.C. 156(d)(5)(B).
Because it is apparent that the
regulatory review period will continue
beyond the extended expiration date of
the patent, November 17, 2011, interim
extension of the patent term under 35
U.S.C. 156(d)(5) is appropriate.
An interim extension under 35 U.S.C.
156(d)(5) of the term of U.S. Patent No.
5,407,914 is granted for a period of one
additional year from the extended
expiration date of the patent, i.e., until
November 17, 2012.
Dated: October 28, 2011.
Robert W. Bahr,
Acting Associate Commissioner for Patent
Examination Policy, United States Patent and
Trademark Office.
[FR Doc. 2011–28499 Filed 11–2–11; 8:45 am]
BILLING CODE 3510–16–P
DEPARTMENT OF COMMERCE
United States Patent and Trademark
Office
[Docket No. PTO–C–2011–0069]
National Medal of Technology and
Innovation Nomination Evaluation
Committee Meeting
United States Patent and
Trademark Office.
ACTION: Notice of closed meeting.
AGENCY:
The National Medal of
Technology and Innovation (NMTI)
Nomination Evaluation Committee will
meet in closed session on Friday,
November 18, 2011. The primary
purpose of the meeting is to discuss the
relative merits of persons, teams and
companies nominated for the 2011
NMTI Medal.
srobinson on DSK4SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
16:50 Nov 02, 2011
Jkt 226001
The meeting will convene
Friday, November 18, 2011, at
approximately 9 a.m., and adjourn at
approximately 5 p.m.
ADDRESSES: The meeting will be held at
the United States Patent and Trademark
Office, 600 Dulany Street, Alexandria,
VA 22314.
FOR FURTHER INFORMATION CONTACT:
Vikrum Aiyer, Program Manager,
National Medal of Technology and
Innovation Program, United States
Patent and Trademark Office, 600
Dulany Street, Alexandria, VA 22314;
telephone (571) 272–8818, or by
electronic mail: nmti@uspto.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to the Federal Advisory Committee Act,
5 U.S.C. app. 2, notice is hereby given
that the NMTI Nomination Evaluation
Committee, chartered to the United
States Department of Commerce, will
meet at the United States Patent and
Trademark Office campus in
Alexandria, Virginia.
The Secretary of Commerce is
responsible for recommending to the
President prospective NMTI Medal
recipients. The NMTI Nomination
Evaluation Committee evaluates the
nominations received pursuant to
public solicitation and makes its
recommendations for the Medal to the
Secretary. Committee members are
distinguished experts in the fields of
science, technology, business and patent
law drawn from both the public and
private sectors and are appointed by the
Secretary for three-year terms.
The NMTI Nomination Evaluation
Committee was established in
accordance with the Federal Advisory
Committee Act (FACA). The Committee
meeting will be closed to the public in
accordance with FACA and 5 U.S.C.
552b(c)(4), (6) and (9)(B), because the
discussion of the relative merit of the
Medal nominations is likely to disclose
information of a personal nature that
would constitute a clearly unwarranted
invasion of personal privacy; premature
disclosure of the Committee’s
recommendations would be likely to
significantly frustrate implementation of
the Medal Program; and the meeting
will include a Department of Commerce
Ethics Division presentation and
question and answer session which may
be closed to protect the privileged and
confidential personal financial
information of Committee members.
The Chief Financial Officer and
Assistant Secretary for Administration,
United States Department of Commerce,
formally determined on October 26,
2011, pursuant to Section 10(d) of the
Federal Advisory Committee Act, that
the meeting may be closed because
DATES:
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
68167
Committee members are concerned with
matters that are within the purview of
5 U.S.C. 552b(c)(4), (6) and (9)(B). Due
to closure of this meeting, copies of any
minutes of the meeting will not be
available. A copy of the determination
is available for public inspection at the
United States Patent and Trademark
Office.
Dated: October 28, 2011.
Teresa Stanek Rea,
Deputy Under Secretary of Commerce for
Intellectual Property and Deputy Director of
the United States Patent and Trademark
Office.
[FR Doc. 2011–28500 Filed 11–2–11; 8:45 am]
BILLING CODE 3510–16–P
COMMODITY FUTURES TRADING
COMMISSION
Sunshine Act Meeting—Emergency
Meeting Notice
This notice that an emergency
meeting was held is published pursuant
to the provisions of the Government in
the Sunshine Act, Public Law 94–409,
5 U.S.C. 552b.
AGENCY HOLDING THE MEETING:
Commodity Futures Trading
Commission.
TIME AND DATE: The Commission held an
emergency closed meeting on October
31, 2011 at 12 p.m. The Commission, by
a recorded unanimous vote, determined
that the agency business required that
business of the agency required that the
meeting be held at that time.
PLACE: Three Lafayette Center, 1155
21st St. NW., Washington, DC, 9th Floor
Commission Conference Room.
STATUS: Closed.
MATTERS TO BE CONSIDERED: Registrant
Financial Matters.
CONTACT PERSON FOR MORE INFORMATION:
Sauntia S. Warfield, Assistant Secretary
of the Commission, 202–418–5084.
Sauntia S. Warfield,
Assistant Secretary of the Commission.
[FR Doc. 2011–28607 Filed 11–1–11; 11:15 am]
BILLING CODE 6351–01–P
CONSUMER PRODUCT SAFETY
COMMISSION
[CPSC Docket No. 12–C0003]
Spin Master, Inc. and Spin Master, Ltd.,
Provisional Acceptance of a
Settlement Agreement and Order
Consumer Product Safety
Commission.
ACTION: Notice.
AGENCY:
E:\FR\FM\03NON1.SGM
03NON1
]]>Agencies
[Federal Register Volume 76, Number 213 (Thursday, November 3, 2011)]
[Notices]
[Page 68167]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-28500]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
United States Patent and Trademark Office
[Docket No. PTO-C-2011-0069]
National Medal of Technology and Innovation Nomination Evaluation
Committee Meeting
AGENCY: United States Patent and Trademark Office.
ACTION: Notice of closed meeting.
-----------------------------------------------------------------------
SUMMARY: The National Medal of Technology and Innovation (NMTI)
Nomination Evaluation Committee will meet in closed session on Friday,
November 18, 2011. The primary purpose of the meeting is to discuss the
relative merits of persons, teams and companies nominated for the 2011
NMTI Medal.
DATES: The meeting will convene Friday, November 18, 2011, at
approximately 9 a.m., and adjourn at approximately 5 p.m.
ADDRESSES: The meeting will be held at the United States Patent and
Trademark Office, 600 Dulany Street, Alexandria, VA 22314.
FOR FURTHER INFORMATION CONTACT: Vikrum Aiyer, Program Manager,
National Medal of Technology and Innovation Program, United States
Patent and Trademark Office, 600 Dulany Street, Alexandria, VA 22314;
telephone (571) 272-8818, or by electronic mail: nmti@uspto.gov.
SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee
Act, 5 U.S.C. app. 2, notice is hereby given that the NMTI Nomination
Evaluation Committee, chartered to the United States Department of
Commerce, will meet at the United States Patent and Trademark Office
campus in Alexandria, Virginia.
The Secretary of Commerce is responsible for recommending to the
President prospective NMTI Medal recipients. The NMTI Nomination
Evaluation Committee evaluates the nominations received pursuant to
public solicitation and makes its recommendations for the Medal to the
Secretary. Committee members are distinguished experts in the fields of
science, technology, business and patent law drawn from both the public
and private sectors and are appointed by the Secretary for three-year
terms.
The NMTI Nomination Evaluation Committee was established in
accordance with the Federal Advisory Committee Act (FACA). The
Committee meeting will be closed to the public in accordance with FACA
and 5 U.S.C. 552b(c)(4), (6) and (9)(B), because the discussion of the
relative merit of the Medal nominations is likely to disclose
information of a personal nature that would constitute a clearly
unwarranted invasion of personal privacy; premature disclosure of the
Committee's recommendations would be likely to significantly frustrate
implementation of the Medal Program; and the meeting will include a
Department of Commerce Ethics Division presentation and question and
answer session which may be closed to protect the privileged and
confidential personal financial information of Committee members.
The Chief Financial Officer and Assistant Secretary for
Administration, United States Department of Commerce, formally
determined on October 26, 2011, pursuant to Section 10(d) of the
Federal Advisory Committee Act, that the meeting may be closed because
Committee members are concerned with matters that are within the
purview of 5 U.S.C. 552b(c)(4), (6) and (9)(B). Due to closure of this
meeting, copies of any minutes of the meeting will not be available. A
copy of the determination is available for public inspection at the
United States Patent and Trademark Office.
Dated: October 28, 2011.
Teresa Stanek Rea,
Deputy Under Secretary of Commerce for Intellectual Property and Deputy
Director of the United States Patent and Trademark Office.
[FR Doc. 2011-28500 Filed 11-2-11; 8:45 am]
BILLING CODE 3510-16-P
